Future Horizons in the Japanese Infectious Disease TestingMarket: Supplier Shares and Sales Forecasts for 100 Tests byMark...
A. Major Infectious Disease Tests1. AIDSa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs2. Adenovirusa. Backgroundb. ...
a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs12. Chagas Diseasea. Background13. Chancroida. Backgroundb. Diagnosti...
a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs23. E. Colia. Backgroundb. Diagnostic Testsc. Vaccines and Drugs24. E...
c. Vaccines and Drugs33. Hepatitisa. Backgroundb. Hepatitis Ac. Hepatitis Bd. Hepatitis Ce. Vaccines and Drugs34. Herpes S...
c. Vaccines and Drugs43. Microsporidiuma. Backgroundb. Diagnostic Testsc. Vaccines and Drugs44. Mononucleosisa. Background...
a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs54. RhinoVirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs...
c. Vaccines and Drugs64. Trichomonas Vaginalisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs65. Tuberculosisa. Back...
C. Market StructureD. Market Size, Growth and Major SuppliersMajor Product Development OpportunitiesA. InstrumentationB. R...
- Gen-Probe- Hologic- ID Biomedical- Innogenetics/Solvay- Kreatech- Life Technology- Lonza- Nanogen/Elitech- Novartis Diag...
Major Companies Developing or Marketing Legionella TestsMajor Companies Developing or Marketing Lyme Disease TestsMajor Co...
JapanHospital Laboratories Infectious Disease TestVolume ForecastJapanBlood Banks Infectious Disease Test Volume ForecastJ...
JapanCampylobacter Test Volume and Diagnostics Sales Forecastby Market SegmentJapanCandida Test Volume and Diagnostics Sal...
by Market SegmentJapanEBV Test Volume and Diagnostics Sales Forecastby Market SegmentJapanGiardia Test Volume and Diagnost...
Hepatitis Delta Test Volume and Diagnostics SalesForecast by Market SegmentJapanHBcAg Test Volume and Diagnostics Sales Fo...
by Market SegmentJapanMicrosporidium Test Volume and Diagnostics Sales Forecastby Market SegmentJapanMononucleosis Test Vo...
Rubella Test Volume and Diagnostics Sales Forecastby Market SegmentJapanSalmonella Test Volume and Diagnostics Sales Forec...
JapanCampylobacter Testing Market Diagnostics Salesby Major SupplierJapanCandida Testing Market Diagnostics Salesby Major ...
RSV Testing Market Diagnostics Sales by Major SupplierJapanRotavirus Testing Market Diagnostics Salesby Major SupplierJapa...
Upcoming SlideShare
Loading in …5
×

Future Horizons in the Japanese Infectious Disease Testing Market: Supplier Shares and Sales Forecasts for 100 Tests by Market Segment

128 views
118 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
128
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Future Horizons in the Japanese Infectious Disease Testing Market: Supplier Shares and Sales Forecasts for 100 Tests by Market Segment

  1. 1. Future Horizons in the Japanese Infectious Disease TestingMarket: Supplier Shares and Sales Forecasts for 100 Tests byMarket SegmentReport Details:Published:August 2012No. of Pages: 976Price: Single User License – US$7800Highlights•Comprehensive 976-page analysis of the Japanese microbiology testing market.•Major issues pertaining to the Japanese microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.•Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.•Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in Japanese hospitals, blood banks and commercial laboratories.•Instrumentation technologies and feature comparison of leading analyzers.•Sales and market shares of leading suppliers.•Emerging diagnostic technologies and their potential market applications.•Product development opportunities.•Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.•Business opportunities and strategic recommendations for suppliers.Contains: 976 pages and 160 tablesGet your copy of this report @http://www.reportsnreports.com/reports/187748-future-horizons-in-the-japanese-infectious-disease-testing-market-supplier-shares-and-sales-forecasts-for-100-tests-by-market-segment.htmlMajor points covered in Table of Contents of this report includeIntroductionWorldwide Market and Technology Overview
  2. 2. A. Major Infectious Disease Tests1. AIDSa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs2. Adenovirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugsd. Adeno-Associated Viruses(AAV)3. Aeromonasa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs4. Anthrax/Bacillus Anthracisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs5. Arbovirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs6. Babesiosisa. Background7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs8. Blastocystis Hominisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs9. Brucellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs10. Campylobactera. Backgroundb. Diagnostic Testsc. Vaccines and Drugs11. Candida
  3. 3. a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs12. Chagas Diseasea. Background13. Chancroida. Backgroundb. Diagnostic Testsc. Vaccines and Drugs14. Chlamydiaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs15. Clostridium Difficilea. Backgroundb. Diagnostic Testsc. Drugs and Vaccines16. Coronavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs17. Coxsackievirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs18. Creutzfeldt-Jakob’s Diseasea. Backgroundb. Diagnostic Testsc. Vaccines19. Cryptosporidium Parvuma. Backgroundb. Diagnostic Testsc. Vaccines and Drugs20. Cyclospora Cayetanensisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs21. Cytomegalovirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs22. Ebola Virus
  4. 4. a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs23. E. Colia. Backgroundb. Diagnostic Testsc. Vaccines and Drugs24. EchoVirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs25. Encephalitisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs26. Enterovirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs27. Epstein-Barr Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs28. Giardia Lambliaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs29. Gonorrheaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs30. Granuloma Inguinalea. Backgroundb. Diagnostic Testsc. Vaccines and Drugs31. Hantavirusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs32. Helicobacter Pyloria. Backgroundb. Diagnostic Tests
  5. 5. c. Vaccines and Drugs33. Hepatitisa. Backgroundb. Hepatitis Ac. Hepatitis Bd. Hepatitis Ce. Vaccines and Drugs34. Herpes Simplex Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs35. Human Herpes Virus-6 (HHV-6)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs36. Influenza Virusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs37. Legionellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs38. Lyme Diseasea. Backgroundb. Diagnostic Testsc. Vaccines and Drugs39. Lymphogranuloma Venereum (LGV)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs40. Malariaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs41. Measles (Rubeola)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs42. Meningitisa. Backgroundb. Diagnostic Tests
  6. 6. c. Vaccines and Drugs43. Microsporidiuma. Backgroundb. Diagnostic Testsc. Vaccines and Drugs44. Mononucleosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs45. Mumpsa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs46. Mycoplasmaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs47. Papillomavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs48. Parvovirus B19a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs49. Pneumoniaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs50. Polyomavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs51. Pseudomonas Aeruginosaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs52. Rabiesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs53. Respiratory Syncytial Virus (RSV)
  7. 7. a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs54. RhinoVirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs55. RotaVirus (REOVIRUS)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs56. Rubella(MEASLES)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs57. Salmonellosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs58. Septicemiaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs59. Shigellosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs60. Staphylococcus Aureusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs61. Streptococcia. Backgroundb. Diagnostic Testsc. Vaccines and Drugs62. Syphilisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs63. Toxoplasmosisa. Backgroundb. Diagnostic Tests
  8. 8. c. Vaccines and Drugs64. Trichomonas Vaginalisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs65. Tuberculosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs66. Vibrioa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs67. West Nile Virusa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs68. Yersinaa. Backgroundb. Diagnostic Testsc. Vaccines and DrugsB. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher,BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other SuppliersC. Emerging Diagnostic Technologies1. Molecular Diagnostics2. Monoclonal Antibodies3. Immunoassays4. Differential Light Scattering5. Information Technology6. Artificial Intelligence7. Liposomes8. Flow Cytometry9. Chromatography10. Diagnostic Imaging11. Gel Microdroplets12. OtherJapanA. Executive SummaryB. Business Environment
  9. 9. C. Market StructureD. Market Size, Growth and Major SuppliersMajor Product Development OpportunitiesA. InstrumentationB. Reagent Kits and Test Systems/PanelsC. Computers, Software and AutomationD. Auxiliary ProductsDesign Criteria for Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for DecentralizedTesting Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market SegmentationPotential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive Assessments- Abbott- Affymetrix- Beckman Coulter/Danaher- Becton Dickinson- bioMerieux- Bio-Rad- Cepheid- Diamedix- DiaSorin- Eiken Chemical- Enzo Biochem- Fujirebio
  10. 10. - Gen-Probe- Hologic- ID Biomedical- Innogenetics/Solvay- Kreatech- Life Technology- Lonza- Nanogen/Elitech- Novartis Diagnostics- Ortho-Clinical Diagnostics- Qiagen- Roche- Scienion- Sequenom- SeraCare- Siemens- Takara Bio- Thermo Fisher- Wallac- WakoList of TablesMajor Companies Developing or Marketing AIDS TestsMajor Companies Developing or Marketing Adenovirus TestsMajor Companies Developing or Marketing Bartonella TestsMajor Companies Developing or Marketing Campylobacter TestsMajor Companies Developing or Marketing Candida TestsMajor Companies Developing or Marketing Chlamydia TestsMajor Companies Developing or Marketing Clostridium TestsMajor Companies Developing or Marketing Coronavirus TestsMajor Companies Developing or Marketing Cryptosporidium TestsMajor Companies Developing or Marketing CMV TestsMajor Companies Developing or Marketing Echovirus TestsMajor Companies Developing or Marketing Enterovirus TestsMajor Companies Developing or Marketing EBV TestsMajor Companies Developing or Marketing Giardia TestsMajor Companies Developing or Marketing Gonorrhea TestsMajor Companies Developing or Marketing Hantavirus TestsMajor Companies Developing or Marketing Helicobacter Pylori TestsMajor Companies Developing or Marketing Hepatitis TestsMajor Companies Developing or Marketing Herpes TestsMajor Companies Developing or Marketing Influenza Tests
  11. 11. Major Companies Developing or Marketing Legionella TestsMajor Companies Developing or Marketing Lyme Disease TestsMajor Companies Developing or Marketing Lymphogranuloma TestsMajor Companies Developing or Marketing Malaria TestsMajor Companies Developing or Marketing Measles TestsMajor Companies Developing or Marketing Meningitis TestsMajor Companies Developing or Marketing Microsporidium TestsMajor Companies Developing or Marketing Mononucleosis TestsMajor Companies Developing or Marketing Mumps TestsMajor Companies Developing or Marketing Mycoplasma TestsMajor Companies Developing or Marketing Papilloma Virus TestsMajor Companies Developing or Marketing Parvovirus TestsMajor Companies Developing or Marketing Pneumonia TestsMajor Companies Developing or Marketing RSV TestsMajor Companies Developing or Marketing Rotavirus TestsMajor Companies Developing or Marketing Rubella TestsMajor Companies Developing or Marketing Salmonella TestsMajor Companies Developing or Marketing Septicemia TestsMajor Companies Developing or Marketing Shigella TestsMajor Companies Developing or Marketing Staphylococci TestsMajor Companies Developing or Marketing Streptococci TestsMajor Companies Developing or Marketing Syphilis TestsMajor Companies Developing or Marketing Toxoplasmosis TestsMajor Companies Developing or Marketing Trichomonas TestsMajor Companies Developing or Marketing Tuberculosis TestsMajor Companies Developing or Marketing West Nile TestsMajor Companies Developing or Marketing Yersinia TestsJapan Summary TableAll Infectious Diseases Test Volume and DiagnosticsSales Forecast by Market SegmentJapanLaboratories Performing Infectious Disease Testsby Market SegmentJapanHospital Laboratories Performing Infectious DiseaseTests by Bed SizeJapanCommercial/Private Laboratories PerformingInfectious Disease Tests by Annual Test VolumeJapanAll Market Segments Infectious Disease Test Volume Forecast
  12. 12. JapanHospital Laboratories Infectious Disease TestVolume ForecastJapanBlood Banks Infectious Disease Test Volume ForecastJapanCommercial/Private Laboratories Infectious DiseaseTest Volume ForecastJapanAll Market Segments Infectious Disease DiagnosticsMarket ForecastJapanHospital Laboratories Infectious Disease DiagnosticsMarket ForecastJapanBlood Banks Infectious Disease Diagnostics Market ForecastJapanCommercial/Private Laboratories Infectious DiseaseDiagnostics Market ForecastJapanHIV or HIV I/HIV II Test Volume and Diagnostics Salesby Market Segment ForecastJapanHIVAg Test Volume and Diagnostics Sales Forecastby Market SegmentJapanWestern Blot/Other Confirmatory Test Volume andDiagnostics Sales Forecast by Market SegmentJapanAdenovirus Test Volume and Diagnostics Sales Forecastby Market SegmentJapanAeromonads Test Volume and Diagnostics Sales Forecastby Market SegmentJapanBEA Test Volume and Diagnostics Sales Forecastby Market SegmentJapanBlastocystis Hominis Test Volume and DiagnosticsSales Forecast by Market Segment
  13. 13. JapanCampylobacter Test Volume and Diagnostics Sales Forecastby Market SegmentJapanCandida Test Volume and Diagnostics Sales Forecastby Market SegmentJapanChancroid Test Volume and Diagnostics Sales Forecastby Market SegmentJapanChlamydia Test Volume and Diagnostics Sales Forecastby Market SegmentJapanClostridium Test Volume and Diagnostics Sales Forecastby Market SegmentJapanCoronavirus Test Volume and Diagnostics Sales Forecastby Market SegmentJapanCoxsackieVirus Test Volume and Diagnostics Sales Forecastby Market SegmentJapanCryptosporidium Test Volume and Diagnostics SalesForecast by Market SegmentJapanCyclospora Test Volume and Diagnostics Sales Forecastby Market SegmentJapanCMV Test Volume and Diagnostics Sales Forecastby Market SegmentJapanE. Coli Test Volume and Diagnostics Sales Forecastby Market SegmentJapanEchovirus Test Volume and Diagnostics Sales Forecastby Market SegmentJapanEncephalitis Test Volume and Diagnostics Sales Forecastby Market SegmentJapanEnterovirus Test Volume and Diagnostics Sales Forecast
  14. 14. by Market SegmentJapanEBV Test Volume and Diagnostics Sales Forecastby Market SegmentJapanGiardia Test Volume and Diagnostics Sales Forecastby Market SegmentJapanGonorrhea Test Volume and Diagnostics Sales Forecastby Market SegmentJapanGranuloma Inguinale Test Volume and DiagnosticsSales Forecast by Market SegmentJapanHantaVirus Test Volume and Diagnostics Sales Forecastby Market SegmentJapanHelicobacter Pylori Test Volume and DiagnosticsSales Forecast by Market SegmentJapanHAV NAT Test Volume and Diagnostics Sales Forecastby Market SegmentJapanHBV NAT Test Volume and Diagnostics Sales Forecastby Market SegmentJapanHBsAg Test Volume and Diagnostics Sales Forecastby Market SegmentJapanHepatitis C Test Volume and Diagnostics Sales Forecastby Market SegmentJapanAnti-HBc Test Volume and Diagnostics Sales Forecastby Market SegmentJapanAnti-HBs Test Volume and Diagnostics Sales Forecastby Market SegmentJapanAnti-HAV Test Volume and Diagnostics Sales Forecastby Market SegmentJapan
  15. 15. Hepatitis Delta Test Volume and Diagnostics SalesForecast by Market SegmentJapanHBcAg Test Volume and Diagnostics Sales Forecastby Market SegmentJapanHBeAg Test Volume and Diagnostics Sales Forecastby Market SegmentJapanALT/SGPT Test Volume and Diagnostics Sales Forecastby Market SegmentJapanHerpes Simplex I and II Test Volume and DiagnosticsSales Forecast by Market SegmentJapanHerpes Type VI Test Volume and Diagnostics SalesForecast by Market SegmentJapanHTLV I or HTLV I/HTLV II Test Volume and DiagnosticsSales Forecast by Market SegmentJapanInfluenza Test Volume and Diagnostics Sales Forecastby Market SegmentJapanLegionella Test Volume and Diagnostics Sales Forecastby Market SegmentJapanLyme Disease Test Volume and Diagnostics Sales Forecastby Market SegmentJapanLymphogranuloma Test Volume and Diagnostics SalesForecast by Market SegmentJapanMalaria Test Volume and Diagnostics Sales Forecast by MarketSegmentJapanMeasles Test Volume and Diagnostics Sales Forecastby Market SegmentJapanMeningitis Test Volume and Diagnostics Sales Forecast
  16. 16. by Market SegmentJapanMicrosporidium Test Volume and Diagnostics Sales Forecastby Market SegmentJapanMononucleosis Test Volume and Diagnostics Sales Forecastby Market SegmentJapanMumps Test Volume and Diagnostics Sales Forecastby Market SegmentJapanMycoplasma Test Volume and Diagnostics Sales Forecastby Market SegmentJapanPapilloma Virus Test Volume and Diagnostics Sales Forecastby Market SegmentJapanParvovirus Test Volume and Diagnostics Sales Forecastby Market SegmentJapanPneumonia Test Volume and Diagnostics Sales Forecastby Market SegmentJapanPolyomaviruses Test Volume and Diagnostics Sales Forecastby Market SegmentJapanPseudomonas Test Volume and Diagnostics Sales Forecastby Market SegmentJapanRabies Test Volume and Diagnostics Sales Forecastby Market SegmentJapanRSV Test Volume and Diagnostics Sales Forecastby Market SegmentJapanRhinovirus Test Volume and Diagnostics Sales Forecastby Market SegmentJapanRotavirus Test Volume and Diagnostics Sales Forecastby Market SegmentJapan
  17. 17. Rubella Test Volume and Diagnostics Sales Forecastby Market SegmentJapanSalmonella Test Volume and Diagnostics Sales Forecastby Market SegmentJapanSepticemia Test Volume and Diagnostics Sales Forecastby Market SegmentJapanShigella Test Volume and Diagnostics Sales Forecastby Market SegmentJapanStaphylococci Test Volume and Diagnostics SalesForecast by Market SegmentJapanStreptococci Test Volume and Diagnostics Sales Forecastby Market SegmentJapanSyphilis Test Volume and Diagnostics Sales Forecastby Market SegmentJapanToxoplasmosis Test Volume and Diagnostics Sales Forecastby Market SegmentJapanTrichomonas Test Volume and Diagnostics Sales Forecastby Market SegmentJapanTuberculosis Test Volume and Diagnostics Sales Forecastby Market SegmentJapanVibrio Test Volume and Diagnostics Sales Forecastby Market SegmentJapanWest Nile Test Volume and Diagnostics Sales Forecastby Market SegmentJapanYersinia Test Volume and Diagnostics Sales Forecastby Market SegmentJapanAIDS Testing Market Diagnostics Salesby Major Supplier
  18. 18. JapanCampylobacter Testing Market Diagnostics Salesby Major SupplierJapanCandida Testing Market Diagnostics Salesby Major SupplierJapanChlamydia Testing Market Diagnostics Salesby Major SupplierJapanCMV Testing Market Diagnostics Salesby Major SupplierJapanGonorrhea Testing Market Diagnostics Salesby Major SupplierJapanHepatitis Testing Market Diagnostics Salesby Major SupplierJapanHepatitis C Testing Market Diagnostics Salesby Major SupplierJapanHerpes Testing Market Diagnostics Salesby Major SupplierJapanLegionella Testing Market Diagnostics Sales Forecastby Major SupplierJapanMeningitis Testing Market Diagnostics Salesby Major SupplierJapanMononucleosis Testing Market Diagnostics Salesby Major SupplierJapanMycoplasma Testing Market Diagnostics Salesby Major SupplierJapanPneumonia Testing Market Diagnostics Salesby Major SupplierJapan
  19. 19. RSV Testing Market Diagnostics Sales by Major SupplierJapanRotavirus Testing Market Diagnostics Salesby Major SupplierJapanRubella Testing Market Diagnostics Salesby Major SupplierJapanSepticemia Testing Market Diagnostics Salesby Major SupplierJapanShigella Testing Market Diagnostics Salesby Major SupplierJapanStreptococci Testing Market Diagnostics Salesby Major SupplierJapanSyphilis Testing Market Diagnostics Salesby Major SupplierJapanToxoplasmosis Testing Market Diagnostics Salesby Major SupplierJapanTrichomonas Testing Market Diagnostics Salesby Major SupplierJapanTuberculosis Testing Market Diagnostics Salesby Major SupplierContact: sales@reportsandreports.com for more information.

×